Tecovirimat hepatotoxicity in a man with Mpox infection

Key Points

• Hepatotoxicity occurred after tecovirimat administration, indicating a possible adverse effect.
• The patient experienced significant liver enzyme elevation, particularly alanine aminotransferase (ALT) levels.
• Assessment based on clinical observations and laboratory tests suggested a direct link to tecovirimat.
• Warning of potential risks underscores the need for careful monitoring during treatment with viral therapies.